Biorevitalisation
VISCODERM references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11210
Viscoderm 0.8
In stock
Volume
3 x 1 mL
Laboratory
IBSA
Origin
Italien
Indication
Biorevitalisation, dry and thin skin, fine lines
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device manufactured by IBSA Farmaceutici Italia S.r.l. It contains 8 mg of highly purified sodium hyaluronate in a 1 ml pre-filled syringe. The hyaluronic acid is obtained by fermentation, is not chemically modified, and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. It is intended for intradermal administration by qualified personnel and is indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis.
Key Benefits of Viscoderm 0.8
- Highly purified hyaluronic acid obtained by fermentation
- Not chemically modified
- Molecular weight of approximately 1 million Dalton
- Supports restoration of physiological hyaluronic acid levels in treated tissue
- Supports tissue rehydration
- Helps create favourable conditions for tissue remodelling
- Indicated for slight xerodermia associated with dermatitis and/or psoriasis
- High biocompatibility and excellent tolerability
- Sterile, pyrogen-free and single-use
Indications and Professional Use
Main indications
- Slight xerodermia associated with dermatitis and/or psoriasis
- Restoration of the normal physiological condition of the dermis
- Rehydration of skin tissue where cell turnover of the stratum corneum is increased
Professional use
Viscoderm 0.8 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.
Treatment areas
- Intradermal administration, at medium-deep level
- The instructions for use do not restrict the device to named facial or body areas; the treating practitioner determines the area treated
Patient profile
Viscoderm 0.8 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 0.8% concentration is indicated to counteract slight xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.
How Viscoderm 0.8 Works
Viscoderm 0.8 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 0.8% concentration is the lightest of the three in the range and is the one indicated for slight xerodermia.
Why Order From Allpara
Allpara offers genuine, verified VISCODERM products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?
The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
Is the hyaluronic acid in Viscoderm 0.8 chemically modified?
No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.
Who should not be treated with Viscoderm 0.8?
Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.
More from IBSA
Aesthetic Skincare
ALIAXIN references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
ALIAXIN Products
View all 6
Dermal Fillers
PROFHILO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
PROFHILO Products
View all 8
SINOVIAL references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
SINOVIAL Products
View all 4
Orthopedics
Clinic alternatives
Mesotherapy
Skin Boosters
/ Recently viewed
Pick up where you left off
Viscoderm 0.8
In stock
CE Marked
Viscoderm 0.8 is a sterile, single-use injectable hyaluronic acid medical device manufactured by IBSA Farmaceutici Italia S.r.l. It contains 8 mg of highly purified sodium hyaluronate in a 1 ml pre-filled syringe. The hyaluronic acid is obtained by fermentation, is not chemically modified, and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. It is intended for intradermal administration by qualified personnel and is indicated to counteract slight xerodermia associated with dermatitis and/or psoriasis.
Key Benefits of Viscoderm 0.8
- Highly purified hyaluronic acid obtained by fermentation
- Not chemically modified
- Molecular weight of approximately 1 million Dalton
- Supports restoration of physiological hyaluronic acid levels in treated tissue
- Supports tissue rehydration
- Helps create favourable conditions for tissue remodelling
- Indicated for slight xerodermia associated with dermatitis and/or psoriasis
- High biocompatibility and excellent tolerability
- Sterile, pyrogen-free and single-use
Indications and Professional Use
Main indications
- Slight xerodermia associated with dermatitis and/or psoriasis
- Restoration of the normal physiological condition of the dermis
- Rehydration of skin tissue where cell turnover of the stratum corneum is increased
Professional use
Viscoderm 0.8 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.
Treatment areas
- Intradermal administration, at medium-deep level
- The instructions for use do not restrict the device to named facial or body areas; the treating practitioner determines the area treated
Patient profile
Viscoderm 0.8 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 0.8% concentration is indicated to counteract slight xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.
How Viscoderm 0.8 Works
Viscoderm 0.8 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 0.8% concentration is the lightest of the three in the range and is the one indicated for slight xerodermia.
Why Order From Allpara
Allpara offers genuine, verified VISCODERM products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Viscoderm 0.8 differ from Viscoderm 1.6 and 2.0?
The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.
Is the hyaluronic acid in Viscoderm 0.8 chemically modified?
No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.
Who should not be treated with Viscoderm 0.8?
Viscoderm 0.8 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. The instructions for use also state that it should not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and that the injection site must be on healthy skin and free of inflammatory processes.
More from IBSA
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.